Insulin Glargine Vs Standard Insulin Therapy
Completed · Phase 3
Conditions studied: Cystic Fibrosis Related Diabetes
In brief
This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin.
Key facts
- Study ID
- NCT00222521
- Run by
- University of Minnesota
- People needed
- 20
- Starts
- 2003-04-01
- Expected to finish
- 2005-08-01
- Last updated by the study team
- 2005-09-22
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.